Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government
ORD only    All VA Research websites

Office of Research & Development

print icon sign up for VA Research updates

Funded Project Details - FY2021




Project Number:

I01CX001734-01A1
Title: Pharmacogenetic Study of Opioid Agonist Treatments in MVP
Principal Investigator:

Kyle M. Kampman

Location: Philadelphia, PA
Congressional District Code: 3
Research Service: Clinical Science R&D
Project Period: April 2019 - March 2022
FY 2021 Funding Amount: $139,767
Total Award Amount
(all years):
$378,175
Abstract: View full abstract and other project information on NIH RePORTER
Go To NIH RePORTER


Excerpt:

1. Objectives: In the US, opioids are widely used for maintenance treatment of opioid use disorder (OUD) and to manage acute and chronic pain. Over the past three decades, efforts to treat pain aggressively in the absence of objective markers to guide opioid prescribing have led to a quadrupling of opioid prescriptions, an epidemic of opioid misuse and abuse, and a tripling of the overdose death rate in the general population and among Veterans. The overarching objective of this proposal is...



Questions about the R&D website? Email the Web Team.

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.